Medical research

Engineered T cells for type 1 diabetes move closer to clinic

For much of the last decade, Dr. David Rawlings, director of Seattle Children's Research Institute's Center for Immunity and Immunotherapies, has dreamed of developing a therapy for children with type 1 diabetes that doesn't ...

Immunology

Breakthrough may explain why cancer immunotherapies can backfire

Research by University of Alberta scientists into PD-1, a cell surface receptor that naturally plays a major role in de-escalating the body's immune system, may explain why it can go haywire and cause autoimmune diseases ...

Oncology & Cancer

Immune therapy takes a 'BiTE' out of brain cancer

Building on their research showing that an exciting new form of immunotherapy for cancer has activity in patients with glioblastoma, the most common and most deadly form of brain cancer, Massachusetts General Hospital (MGH) ...

Immunology

A new toolkit to engineer safe and efficient therapeutic cells

Therapies based on engineered immune cells have recently emerged as a promising approach in the treatment of cancer. Compared to traditional drugs, engineered immune cells are more precise and sophisticated in their ability ...

page 2 from 26